These Tg hSMN2 E9 inducible SMN transgenic mice conditionally express a human SMN2 cDNA. Widespread lacZ expression is observed except in those tissues where cre recombination has resulted in the human SMN2 cDNA to be expressed instead. These transgenic mice are suitable for use in studies related to Spinal Muscular Atrophy.
Dawn S Chandler, The Ohio State University School of Med.
Genetic Background | Generation |
---|---|
|
Allele Type |
---|
Transgenic (Conditional ready (e.g. floxed), Reporter, Inserted expressed sequence, Humanized sequence) |
These Tg hSMN2 E9 inducible SMN transgenic mice have a loxP-flanked β-geo STOP cassette preventing transcription of a downstream full-length human SMN2 cDNA sequence (exons 1-8). Prior to Cre recombinase exposure, β-galactosidase (lacZ) expression is directed to widespread tissues by the CMV-IE enhancer/chicken β-actin/rabbit β-globin hybrid promoter, and no human SMN2 expression is observed. When bred to mice that express Cre recombinase, the resulting offspring will have the floxed β-geo STOP cassette deleted in the cre-expressing tissues; resulting in expression of full-length human SMN2 in cre-expressing tissues (and continued lacZ expression in other tissues). The donating investigator reports that Tg hSMN2 E9 inducible SMN transgenic mice do not express human SMN2 prior to introduction of Cre recombinase. Mice hemizygous for the inducible SMN transgene are viable and fertile, with no reported phenotypic abnormalities. The phenotype of homozygous mice has not been characterized by the donating investigator to date (May 2012). These Tg hSMN2 E9 inducible SMN transgenic mice allow induction of full-length SMN2 cDNA after Cre-mediated recombination, and are suitable for use in studies related to Spinal Muscular Atrophy.
The pCCALL2/hSMN2 transgene was designed with, from 5' to 3', the CMV-IE enhancer/chicken β-actin/rabbit β-globin hybrid promoter (originally from the pCAGG vector), a loxP-flanked STOP cassette (β-galactosidase/neomycin resistance cassette [β-geo] with three copies of the SV40 polyA signal), the 1.37 kbp full-length human SMN2 cDNA sequence including all exons (1-8) from the start codon to the stop codon, and a rabbit polyA signal. The 1.37 kbp human SMN2 cDNA sequence (encoding exons 1-8) was originally derived via RT-PCR performed on total RNA isolated from SMA type 1-derived patient fibroblast cells (Coriell Institute GM 3813; shown to express both full-length and truncated SMN2 transcripts). The transgene was electroporated into 129S6/SvEvTac-derived TC1 embryonic stem (ES) cells. ES cell clone E9 was identified with a single insertion site and high expression of the lacZ reporter. Clone E9 was injected into blastocysts, which were then implanted into pseudopregnant females. Chimeric offspring were bred to C57BL/6J mice to establish the colony. Transgene positive (Tg hSMN2 E9) mice were then bred to C57BL/6J mice for at least ten additional generations prior to sending to The Jackson Laboratory Repository. Upon arrival, mice were bred with C57BL/6J inbred mice (Stock No. 000664) for at least one generation to establish The Jackson Laboratory Repository colony.
Expressed Gene | SMN2, survival of motor neuron 2, centromeric, human |
---|---|
Expressed Gene | Bgeo, fusion of beta-galactosidase and neomycin phosphotransferase genes, E. coli |
Site of Expression | lacZ expression is seen in all cells prior to Cre recombination. After cre excision of the floxed- lacZ-neo cassette, human SMN2 is expressed in cre-expressing tissues. |
Allele Name | transgene insertion E9, Dawn S Chandler |
---|---|
Allele Type | Transgenic (Conditional ready (e.g. floxed), Reporter, Inserted expressed sequence, Humanized sequence) |
Allele Synonym(s) | Tg hSMN2 E9 |
Gene Symbol and Name | Tg(CAG-Bgeo,-SMN2)E9Dscd, transgene insertion E9, Dawn S Chandler |
Gene Synonym(s) | |
Promoter | CMV, cytomegalovirus, human |
Expressed Gene | SMN2, survival of motor neuron 2, centromeric, human |
Expressed Gene | Bgeo, fusion of beta-galactosidase and neomycin phosphotransferase genes, E. coli |
Site of Expression | lacZ expression is seen in all cells prior to Cre recombination. After cre excision of the floxed- lacZ-neo cassette, human SMN2 is expressed in cre-expressing tissues. |
Strain of Origin | 129S6/SvEvTac |
Chromosome | UN |
Molecular Note | The pCCALL2/hSMN2 transgene was designed with, from 5' to 3', the CMV-IE enhancer/chicken beta-actin/rabbit beta-globin hybrid promoter (originally from the pCAGG vector), a loxP-flanked STOP cassette (beta-galactosidase/neomycin resistance cassette [beta-geo] with three copies of the SV40 polyA signal), the 1.37 kbp full-length human SMN2 cDNA sequence including all exons (1-8) from the start codon to the stop codon, and a rabbit polyA signal. The 1.37 kbp human SMN2 cDNA sequence (encoding exons 1-8) was originally derived via RT-PCR performed on total RNA isolated from SMA type 1-derived patient fibroblast cells (Coriell Institute GM 3813; shown to express both full-length and truncated SMN2 transcripts). Lines A9 and E9 was generated. |
Mutations Made By | Dawn Chandler, The Ohio State University School of Med. |
When maintaining a live colony, transgenic mice may be bred with wildtype (noncarrier) mice from the colony or with C57BL/6J inbred mice (Stock No. 000664).
When using the B6.129S6-Tg(CAG-Bgeo,-SMN2)E9Dscd/J mouse strain in a publication, please cite the originating article(s) and include JAX stock #018439 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Hemizygous or Non Carrier for Tg(CAG-Bgeo,-SMN2)E9Dscd |
Frozen Mouse Embryo | B6.129S6-Tg(CAG-Bgeo-SMN2)E9Dscd/J | $2595.00 |
Frozen Mouse Embryo | B6.129S6-Tg(CAG-Bgeo-SMN2)E9Dscd/J | $2595.00 |
Frozen Mouse Embryo | B6.129S6-Tg(CAG-Bgeo-SMN2)E9Dscd/J | $3373.50 |
Frozen Mouse Embryo | B6.129S6-Tg(CAG-Bgeo-SMN2)E9Dscd/J | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.